A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial)

BACKGROUND: In an oligometastatic setting, metastasis-directed treatment could render patients disease free, possibly for a protracted interval. Stereotactic ablative radiotherapy (SABR) is one of the treatment modalities that can be offered to these patients. In addition, the radiobiological qualit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mercier, Carole, Dirix, Piet, Meijnders, Paul, Vermeulen, Peter, Van Laere, Steven, Debois, Hilde, Huget, Philippe, Verellen, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102883/
https://www.ncbi.nlm.nih.gov/pubmed/30126440
http://dx.doi.org/10.1186/s13014-018-1096-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102883/
https://www.ncbi.nlm.nih.gov/pubmed/30126440
http://dx.doi.org/10.1186/s13014-018-1096-9

Ejemplares similares